Vycor Medical (VYCO) Liabilities and Shareholders Equity (2010 - 2026)
Vycor Medical (VYCO) reported Liabilities and Shareholders Equity of $854071.0 for Q1 2026, down 9.22% year-over-year from $940831.0 in Q1 2025, and up 2.85% quarter-over-quarter from $830420.0 in Q4 2025.
Vycor Medical (VYCO) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has 17 years of Liabilities and Shareholders Equity data on file, last reported at $854071.0 in Q1 2026.
- Liabilities and Shareholders Equity for Q1 2026 came in at $854071.0, down 9.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.5 million (down 12.61% YoY), and the FY2025 annual result was $830420.0, down 16.8% from the prior year.
- Liabilities and Shareholders Equity grew to $854071.0 in Q1 2026 per VYCO's latest filing, from $830420.0 in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $1.1 million in Q3 2024 and troughed at $830420.0 in Q4 2025.
- A 5-year average of $936733.2 and a median of $940831.0 in 2025 frame the typical range for Liabilities and Shareholders Equity.
- The sharpest annual moves came in 2024 and 2025: Liabilities and Shareholders Equity rose 16.0% in 2024, then slipped 16.8% in 2025.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $860178.0 in 2022, then rose by 15.36% to $992298.0 in 2023, then climbed by 0.59% to $998117.0 in 2024, then declined by 16.8% to $830420.0 in 2025, then rose by 2.85% to $854071.0 in 2026.
- Business Quant data shows VYCO's Liabilities and Shareholders Equity at $854071.0 in Q1 2026, $830420.0 in Q4 2025, and $941195.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 10.74 Bn |
| 10 | Vycor Medical | - | - | 375,153.00 | 854,071.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 854,071.00 |
| Dec 31, 2025 | 830,420.00 |
| Sep 30, 2025 | 941,195.00 |
| Jun 30, 2025 | 878,946.00 |
| Mar 31, 2025 | 940,831.00 |
| Dec 31, 2024 | 998,117.00 |
| Sep 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 996,972.00 |
| Mar 31, 2024 | 968,792.00 |
| Dec 31, 2023 | 992,298.00 |
| Sep 30, 2023 | 1.05 Mn |
| Jun 30, 2023 | 905,438.00 |
| Mar 31, 2023 | 835,156.00 |
| Dec 31, 2022 | 860,178.00 |
| Sep 30, 2022 | 949,816.00 |
| Jun 30, 2022 | 910,182.00 |
| Mar 31, 2022 | 932,979.00 |
| Dec 31, 2021 | 935,364.00 |
| Sep 30, 2021 | 1.04 Mn |
| Jun 30, 2021 | 1.06 Mn |